Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus plus low-dose ciclosporin for renal function in adult heart transplant recipients
2006-002786-39Phase 4Active
- Sponsor
- Papa Giovanni XXIII Hospital
- Start
- Nov 2007
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in graft rejection and Renal Insufficiency (RI) comparing Everolimus plus low-dose ciclosporin with Ciclosporin control (2 arms). Started Nov 2007; status: active.
02
Drugs
everolimuscyclosporine
03
Conditions
graft rejectionRenal Insufficiency (RI)
Beyond the preview
Go deeper on 2006-002786-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002786-39.